People who combined regular aerobic exercise with strength training had a 41% to 47% lower risk of dying from any cause compared with those who did neither, according to a pooled analysis of three major U.S. prospective cohorts tracking 147,374 participants and 35,798 deaths over decades. The finding, drawn from the Health Professionals Follow-up Study and two Nurses’ Health Studies, suggests that neither running nor lifting alone delivers the same survival advantage as doing both. For anyone deciding how to split limited workout time, the data point toward a clear answer: mix it up.
Why the combined-training mortality gap demands attention now
The scale of the benefit reported here is hard to ignore. A roughly 45% reduction in all-cause mortality sits well above what most single lifestyle interventions can claim. And the advantage is not simply a matter of doing more total exercise. The pooled cohort analysis published in the British Journal of Sports Medicine, available via PubMed indexing, assessed resistance training and aerobic activity separately and together, finding that the joint effect exceeded what either modality produced on its own.
Strength training alone, at a dose of 90 to 120 minutes per week, was linked to a 13% lower all-cause mortality risk compared with no strength training. That same dose was tied to a 19% lower cardiovascular mortality risk and a 27% lower risk of death from neurological diseases, according to the Harvard T.H. Chan School of Public Health. The neurological-disease figure is striking because it is the largest single cause-specific reduction reported at that strength-training volume, raising the question of whether the combined-training mortality benefit is driven more by neurological protection than by heart-health gains once weekly lifting exceeds 90 minutes.
Testing that hypothesis would require re-running cause-specific models on the existing Health Professionals Follow-up Study and Nurses’ Health Study datasets, stratified by strength-training duration. The published summaries do not release the full subgroup hazard ratios needed to confirm or reject it. But the pattern is suggestive: if strength training’s largest standalone payoff is against neurological-disease death, then the added value of aerobic exercise in the combined regimen may be doing most of the cardiovascular heavy lifting, while resistance work contributes disproportionately on the neurological side.
Three cohorts, 147,374 participants, and converging dose-response curves
The primary analysis pooled data from the Health Professionals Follow-up Study (1992 to 2022), the Nurses’ Health Study (2002 to 2021), and the Nurses’ Health Study II (2003 to 2021). Participants reported their exercise habits every two years, giving researchers repeated snapshots rather than a single baseline measurement. That design reduces the risk that a person’s activity level at enrollment misrepresents their long-term behavior, a common weakness in exercise-mortality research.
Across 147,374 participants and 35,798 recorded deaths, the data showed a clear dose-response relationship for strength training up to a point. The sweet spot for mortality reduction from resistance exercise alone fell between 90 and 120 minutes per week. But the largest gains appeared when participants also met aerobic activity guidelines, pushing the combined mortality reduction into the 41% to 47% range compared with people who did neither type of exercise, as reported by Harvard Health Publishing.
These results do not exist in isolation. A separate national cohort study of 416,420 U.S. adults, also published in the British Journal of Sports Medicine, found similar dose-response patterns for aerobic and muscle-strengthening activity with mortality. And a systematic review and meta-analysis of cohort studies examining muscle-strengthening behavior and mortality from major non-communicable diseases reinforced the same conclusion: combining modalities produces a benefit that exceeds the sum of its parts. The convergence across different study designs and populations strengthens the case that the association is real, even if causation cannot be proven from observational data alone.
Self-reported exercise and missing subgroup data limit the picture
The cohorts relied entirely on biennial self-reported questionnaires to measure exercise. No accelerometer data, fitness-tracker logs, or objective performance tests were used to validate what participants said they did. Self-reports tend to overestimate activity levels, which means the true dose thresholds for mortality reduction could differ from the 90-to-120-minute weekly window identified in the analysis. Until a large cohort study with device-measured activity replicates these findings, the precision of those numbers carries some uncertainty.
Detailed cause-specific mortality tables broken down by age, sex, and baseline health status have not been released in the publicly available summaries. That gap matters because the practical advice changes depending on who benefits most. A 40-year-old woman with no chronic conditions and a 70-year-old man with early cognitive decline face very different risk profiles. Without published subgroup hazard ratios, clinicians and public-health officials are left extrapolating from aggregate data that may obscure meaningful differences in benefit or risk.
Another limitation is that the cohorts primarily included health professionals, a group that tends to have higher education levels, better access to care, and different lifestyle patterns than the general population. These factors could interact with exercise habits in ways that influence mortality. While the biological mechanisms linking activity to health outcomes are likely similar across groups, the magnitude of benefit might not be identical in more socioeconomically diverse populations.
Residual confounding also cannot be ruled out. People who regularly perform both aerobic and strength training may differ from less active peers in diet, sleep, alcohol use, or adherence to medical advice. The analyses adjusted for many of these variables, but unmeasured factors could still inflate the apparent protective effect of combined training. That said, the consistent dose-response curves across multiple cohorts and the corroborating evidence from independent meta-analyses make it unlikely that confounding alone explains a 40%-plus mortality difference.
How much and what kind of exercise this evidence supports
Despite the caveats, the emerging picture aligns well with existing public-health guidance. Current recommendations generally call for at least 150 minutes per week of moderate-intensity aerobic activity, plus two or more days of muscle-strengthening exercises. The pooled analysis suggests that reaching roughly 90 to 120 minutes per week of resistance work, alongside guideline-level aerobic activity, may capture much of the survival advantage seen in the combined-training group.
In practice, that could mean three or four 30-minute strength sessions each week, paired with brisk walking, cycling, or similar aerobic work on most days. The exact mix is less important than consistently engaging both systems: the heart-lung endurance challenged by aerobic exercise and the muscle and neuromuscular networks targeted by resistance training.
For people with limited time or mobility constraints, even smaller amounts appear to confer some benefit. Both the pooled cohorts and the broader literature indicate that moving from no activity to modest levels of either modality reduces mortality risk, with diminishing returns at higher doses. The sharpest drop in risk often occurs with the first few hours per week of combined movement.
What researchers and clinicians should watch next
Future work will need to clarify whether certain populations derive outsized gains from combined training and to disentangle which causes of death are most affected. Large-scale cohorts that incorporate wearable devices, imaging, and biomarker panels could help map specific physiological pathways linking dual-modality exercise to longevity.
For now, the message for practice is straightforward: when counseling patients or designing public-health campaigns, emphasizing both aerobic and strength components appears justified. The mortality gap between people who do neither and those who do both is too large, and too consistently observed, to ignore.
Researchers and clinicians looking to explore the underlying studies and related work can turn to resources such as the National Library of Medicine, which aggregates peer-reviewed evidence on exercise, chronic disease, and mortality. As more granular data emerge, the hope is that guidance on how to blend cardio and strength training can become not just broadly persuasive, but precisely tailored to the individuals who stand to gain the most.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
